Skip to Main Content

Author Details

Joy Hendley
Peter MacCallum Cancer Centre
1997
22
16
PMIDPaper TitleJournal TitlePublished Year
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
36849657Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.Nat Genet2023
35263119TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.J Clin Oncol2022
36456881The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.Nat Genet2022
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
30967419Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype.Clin Cancer Res2019
30894541Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer.Nat Commun2019
29061645Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.Clin Cancer Res2018
30062862Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2018
28646021<i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas.Cancer Res2017
26017449Whole-genome characterization of chemoresistant ovarian cancer.Nature2015
26503049Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.Nature2015
22896685LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.Cancer Res2012
12738746Cyclin d1 overexpression sensitizes breast cancer cells to fenretinide.Clin Cancer Res2003
12853979Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.Oncogene2003
11595732Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2.J Biol Chem2001
10766840Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286.J Biol Chem2000
10597247Inhibitory effect of p21 in MCF-7 cells is overcome by its coordinated stabilization with D-type cyclins.Oncogene1999
10208420Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.Oncogene1999
9264468DNA damage inhibits proteolysis of the B-type cyclin Clb5 in S. cerevisiae.J Cell Sci1997
  • 1 - 22 of 22

Recommended Authors

Andrea C Chaikovsky
Stanford University
Career Start Year 2016
Number of shared co-authors 0
Hana Paculova
University of Vermont
Career Start Year 2015
Number of shared co-authors 0
Laura Pontano Vaites
Harvard Medical School
Career Start Year 2007
Number of shared co-authors 0
Anna V??h??rautio
University of Helsinki
Career Start Year 2006
Number of shared co-authors 2
Kizhakke M Sathyan
Center for Cell Analysis and Modeling, University of Connecticut
Career Start Year 2005
Number of shared co-authors 0
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year 2004
Number of shared co-authors 0
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 19
Jamie M Keck
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2001
Number of shared co-authors 0
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Tarek Abbas
University of Virginia
Career Start Year 2001
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 4
Shiaw-Yih Lin
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
John Alan Diehl
Case Western Reserve University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 2
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 1
Rong Li
University of Texas Health
Career Start Year 1989
Number of shared co-authors 0
Eldad Zacksenhaus
University of Toronto
Career Start Year 1988
Number of shared co-authors 1
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 4
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 6
Alvaro N A Monteiro
H. Lee Moffitt Cancer Center & Research Institute
Career Start Year 1985
Number of shared co-authors 72
Subrata Sen
UT MD Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 0
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 0
Ashok R Venkitaraman
University of Cambridge, Hutchison Research Centre
Career Start Year 1982
Number of shared co-authors 3
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 59
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 2
J. Wade Harper
Harvard Medical School
Career Start Year 1981
Number of shared co-authors 1
Stanley Lipkowitz
Center for Cancer Research, National Cancer Institute
Career Start Year 1978
Number of shared co-authors 2
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 82
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 34

Collaborators

Sian Fereday
Peter MacCallum Cancer Centre
Co-authored papers 15
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 15
Anna DeFazio
Westmead Hospital
Co-authored papers 12
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 10
Paul Harnett
Westmead Clinical School, University of Sydney
Co-authored papers 10
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers 9
Martin K??bel
University of Calgary
Co-authored papers 8
Kathryn Alsop
Peter MacCallum Cancer Centre
Co-authored papers 8
Doris Germain
Co-authored papers 7
Joshy George
Peter MacCallum Cancer Centre
Co-authored papers 7
Yoke-Eng Chiew
Westmead Hospital
Co-authored papers 6
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 6
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 6
Dariush Etemadmoghadam
Peter MacCallum Cancer Centre
Co-authored papers 6
Stacey J Winham
Mayo Clinic
Co-authored papers 6
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 6
Raghwa Sharma
Westmead Hospital
Co-authored papers 6
Michael S Anglesio
University of British Columbia
Co-authored papers 6
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 6
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 5
Brenda Y Hernandez
University of Hawaii Cancer Center
Co-authored papers 5
Jennifer Alsop
University of Cambridge
Co-authored papers 5
Mercedes Jimenez-Linan
University of Cambridge
Co-authored papers 5
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 5
Aline Talhouk
The University of British Columbia
Co-authored papers 5
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 5
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 5
Michael E Carney
John A. Burns School of Medicine, University of Hawaii
Co-authored papers 5
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 5
George Au-Yeung
The University of Melbourne
Co-authored papers 5
Release 1.2